ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2015. The put-call ratio across all filers is 1.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $409,000 | -65.1% | 9,566 | -65.0% | 0.02% | -66.1% |
| Q3 2019 | $1,171,000 | -53.5% | 27,366 | -42.1% | 0.06% | -53.9% |
| Q3 2017 | $2,516,000 | +952.7% | 47,245 | +1289.6% | 0.13% | +814.3% |
| Q4 2016 | $239,000 | -38.6% | 3,400 | -44.7% | 0.01% | -17.6% |
| Q1 2016 | $389,000 | +13.7% | 6,153 | +101.5% | 0.02% | +6.2% |
| Q4 2015 | $342,000 | -81.9% | 3,053 | -83.5% | 0.02% | -74.6% |
| Q2 2015 | $1,893,000 | – | 18,493 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |